Stuart Hughes is currently the CEO of Pathios Therapeutics and the Co-founder of ThirtyFiveBio. Prior to their current roles, Stuart held various positions at Vertex Pharmaceuticals and Eli Lilly. With a background in neuroscience and electrical & electronic engineering, Stuart's career includes research and academic roles at Cardiff University, as well as experience in the pharmaceutical and systems analysis industries.
April, 2021 - present